BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 55321)

  • 1. [Androgens].
    Shida K; Ito Z; Yamanaka H
    Horumon To Rinsho; 1975 Dec; 23(12):1203-19. PubMed ID: 55321
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
    Krieg M; Bartsch W; Janssen W; Voigt KD
    J Steroid Biochem; 1979 Jul; 11(1B):615-24. PubMed ID: 90754
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular action of androgen in the normal and neoplastic prostate.
    Kokontis JM; Liao S
    Vitam Horm; 1999; 55():219-307. PubMed ID: 9949683
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate diseases--role of sex steroids and their inhibitors.
    Welén K; Damber JE
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):355-67. PubMed ID: 21397203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen action: molecular mechanism and medical application.
    Liao S
    J Formos Med Assoc; 1994 Sep; 93(9):741-51. PubMed ID: 7735002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent studies on the mechanism of action of testosterone.
    Wilson JD
    N Engl J Med; 1972 Dec; 287(25):1284-91. PubMed ID: 4119318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 8. Androgen receptors in benign and malignant prostatic tissue.
    Lakey WH; Bruchovsky N; Callaway T; Comeau T; Lieskovsky G; Rennie P; Shnitka T; Wilkin P
    Trans Am Assoc Genitourin Surg; 1979; 71():19-22. PubMed ID: 94714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases.
    Cabeza M; Sánchez-Márquez A; Garrido M; Silva A; Bratoeff E
    Curr Med Chem; 2016; 23(8):792-815. PubMed ID: 26861003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormonal signaling in prostatic hyperplasia and neoplasia.
    Marcelli M; Cunningham GR
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3463-8. PubMed ID: 10522981
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer.
    Nishiyama T; Hashimoto Y; Takahashi K
    Clin Cancer Res; 2004 Nov; 10(21):7121-6. PubMed ID: 15534082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ockham's razor and selective androgen receptor modulators (SARMs): are we overlooking the role of 5alpha-reductase?
    Gao W; Dalton JT
    Mol Interv; 2007 Feb; 7(1):10-3. PubMed ID: 17339601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential test systems for chemotherapeutic agents against prostatic cancer.
    Sandberg AA
    Vitam Horm; 1975; 33():155-88. PubMed ID: 820067
    [No Abstract]   [Full Text] [Related]  

  • 14. Altered androgen metabolism in metastatic prostate cancer.
    Kliman B; Prout GR; Maclaughlin RA; Daly JJ; Griffin PP
    J Urol; 1978 May; 119(5):623-6. PubMed ID: 77915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Steroid substances--androgens].
    Shimazaki J; Fuse H; Akimoto S
    Nihon Rinsho; 1986 Jan; 44(1):122-9. PubMed ID: 2421025
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid levels in cancer of the prostate--markers of tumour differentiation and adequacy of anti-androgen therapy.
    Geller J; Albert J; Loza D
    J Steroid Biochem; 1979 Jul; 11(1B):631-6. PubMed ID: 491627
    [No Abstract]   [Full Text] [Related]  

  • 17. Syndromes of androgen resistance.
    Griffin JE; Wilson JD
    Hosp Pract (Off Ed); 1987 Aug; 22(8):159-64, 166, 169 passim. PubMed ID: 3114273
    [No Abstract]   [Full Text] [Related]  

  • 18. The relevance of studies on androgen action to prostatic cancer.
    Mainwaring WI
    Curr Top Mol Endocrinol; 1976; 4():152-71. PubMed ID: 800357
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical aspects of the anti-androgens].
    Holtzhausen GH
    S Afr Med J; 1979 Mar; 55(13):516-21. PubMed ID: 156405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some clinically relevant findings in recent research on androgens].
    Tamm J; Voigt KD
    Schweiz Med Wochenschr; 1971 Jul; 101(30):1078-83. PubMed ID: 4110881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.